{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:46:19Z","timestamp":1776573979565,"version":"3.51.2"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230003"],"award-info":[{"award-number":["82230003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81820108003"],"award-info":[{"award-number":["81820108003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijbiomac.2025.140739","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:52:36Z","timestamp":1738896756000},"page":"140739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["A novel antibody against GPIb\u03b1 inhibits platelet function and thrombosis without increasing bleeding"],"prefix":"10.1016","volume":"304","author":[{"given":"Lili","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenglin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.140739_bb0005","first-page":"64","article-title":"Coronary heart disease in sub-Saharan Africa: still rare, misdiagnosed or underdiagnosed?","volume":"6","author":"Nkoke","year":"2016","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0010","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1474-4422(19)30415-6","article-title":"Advances and challenges in stroke rehabilitation","volume":"19","author":"Stinear","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0015","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/CIRCULATIONAHA.116.024531","article-title":"Impact of optimal medical therapy in the dual antiplatelet therapy study","volume":"134","author":"Resor","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620980067","article-title":"Long-term safety and efficacy of antiplatelet therapy in patients with cerebral infarction with thrombocytopenia","volume":"27","author":"Guo","year":"2021","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/13543784.2019.1559814","article-title":"Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agents","volume":"28","author":"Yandrapalli","year":"2019","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.amjmed.2022.01.042","article-title":"Antiplatelet agents in acute st elevation myocardial infarction","volume":"135","author":"Kumar","year":"2022","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0035","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1198","article-title":"Antiplatelet therapy: in search of the \u2018magic bullet\u2019","volume":"2","author":"Jackson","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0040","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0045","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/chir.22742","article-title":"Developments in the synthesis of the antiplatelet and antithrombotic drug (S)-clopidogrel","volume":"29","author":"Saeed","year":"2017","journal-title":"Chirality"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/2211738508666200708150151","article-title":"Formulation and in vivo evaluation of Ticagrelor self-nanoemulsifying drug delivery systems","volume":"9","author":"Aparna","year":"2021","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/cplu.201900086","article-title":"Insight into the biological activity of organometallic acetylsalicylic acid (aspirin) derivatives","volume":"84","author":"Kowalski","year":"2019","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0060","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41569-023-00854-6","article-title":"Current concepts and novel targets for antiplatelet therapy","volume":"20","author":"Gawaz","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0065","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(00)02175-9","article-title":"Platelets","volume":"355","author":"George","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.prostaglandins.2015.03.011","article-title":"Antiplatelet drug resistance: molecular insights and clinical implications","volume":"120","author":"Floyd","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0075","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0032-1328881","article-title":"Drugs that affect platelet function","volume":"38","author":"Scharf","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1160\/TH07-12-0718","article-title":"Platelet GPIb\u03b1 complex as a target for anti-thrombotic drug development","volume":"99","author":"Clemetson","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/187152906778249536","article-title":"Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs","volume":"6","author":"De Meyer","year":"2006","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0090","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.3390\/molecules26164911","article-title":"Soy isoflavones inhibit both GPIb-IX signaling and \u03b1IIb\u03b23 outside-in signaling via 14-3-3\u03b6 in platelet","volume":"26","author":"Liu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0095","first-page":"55","article-title":"Development of antibodies that interfere with the collagen-VWF-GPIb\u03b1 axis as new antithrombotics","volume":"67","author":"Deckmyn","year":"2005","journal-title":"Verh. K. Acad. Geneeskd. Belg."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0100","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jtha.2022.12.030","article-title":"Dual roles of fucoidan-GPIb\u03b1 interaction in thrombosis and hemostasis: implications for drug development targeting GPIb\u03b1","volume":"21","author":"Shen","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0105","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/164_2019_323","article-title":"Monoclonal antibodies: past, present and future","volume":"260","author":"Posner","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood.V95.3.886.003k45_886_893","article-title":"Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies","volume":"95","author":"Bergmeier","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0115","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/d41573-021-00079-7","article-title":"FDA approves 100th monoclonal antibody product","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0120","first-page":"262","article-title":"US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives","volume":"4","author":"Wang","year":"2021","journal-title":"Antib Ther."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0125","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1111\/bph.13178","article-title":"A novel snake venom-derived GPIb\u03b1 antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury","volume":"172","author":"Li","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12959-016-0085-1","article-title":"Erratum to: \u2018Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program\u2019","volume":"14","author":"Yamada","year":"2016","journal-title":"Thromb. J."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0135","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1182\/asheducation-2018.1.539","article-title":"Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura","volume":"2018","author":"Dane","year":"2018","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/hq0202.102321","article-title":"Inhibition of platelet glycoprotein Ib\u03b1, glycoprotein IIb\/IIIa, or both by monoclonal antibodies prevents arterial thrombosis in baboons","volume":"22","author":"Wu","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0145","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/jama.1975.03260050050021","article-title":"Personal prophylaxis for venereal diseases","volume":"233","author":"Darrow","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0150","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.ATV.20.5.1347","article-title":"Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody fab fragments in nonhuman primates","volume":"20","author":"Cauwenberghs","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/hq0102.101520","article-title":"Pharmacokinetics and pharmacodynamics of AJW200, a humanized monoclonal antibody to von Willebrand factor, in monkeys","volume":"22","author":"Kageyama","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41573-020-0061-0","article-title":"Therapeutic strategies for thrombosis: new targets and approaches","volume":"19","author":"Mackman","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0165","first-page":"1","article-title":"Human monoclonal antibodies: the benefits of humanization","volume":"2019","author":"Waldmann","year":"1904","journal-title":"Methods Mol. BioI."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0170","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1160\/TH08-02-0073","article-title":"The humanized anti-glycoprotein Ib\u03b1 monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons","volume":"100","author":"Fontayne","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0175","doi-asserted-by":"crossref","first-page":"E10682","DOI":"10.1073\/pnas.1808217115","article-title":"Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0180","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood.V69.2.570.570","article-title":"A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen","volume":"69","author":"Ruan","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0185","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.123.064121","article-title":"Jmjd4 facilitates Pkm2 degradation in cardiomyocytes and is protective against dilated cardiomyopathy","volume":"147","author":"Tang","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0190","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41564-023-01357-3","article-title":"Modulation of virus-induced neuroinflammation by the autophagy receptor SHISA9 in mice","volume":"8","author":"Zheng","year":"2023","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0195","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1182\/blood-2015-04-638387","article-title":"Signaling-mediated cooperativity between glycoprotein Ib-IX and protease-activated receptors in thrombin-induced platelet activation","volume":"127","author":"Estevez","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1160\/TH14-03-0217","article-title":"Glycoprotein Ib\u03b1 clustering induces macrophage-mediated platelet clearance in the liver","volume":"113","author":"Yan","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0205","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/00365510600763319","article-title":"In vivo veritas: thrombosis mechanisms in animal models","volume":"66","author":"Napoli","year":"2006","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0210","first-page":"96","article-title":"Practical murine hematopathology: a comparative review and implications for research","volume":"65","author":"O\u2019Connell","year":"2015","journal-title":"Comp. Med."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0215","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood.V96.7.2520","article-title":"Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice","volume":"96","author":"Nieswandt","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0220","doi-asserted-by":"crossref","first-page":"13696","DOI":"10.1038\/s41598-020-70680-0","article-title":"Antibody-protein binding and conformational changes: identifying allosteric signalling pathways to engineer a better effector response","volume":"10","author":"Al Qaraghuli","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000217286","article-title":"Which experimental model to choose to study arterial thrombosis and evaluate potentially useful therapeutics?","volume":"26","author":"Andre","year":"1996","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0230","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/s41467-019-09150-9","article-title":"Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk","volume":"10","author":"Ting","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0235","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.toxicon.2004.07.022","article-title":"TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb\u03b1","volume":"44","author":"Tai","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0240","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1055\/s-0037-1613473","article-title":"Thrombin binding to GPIb\u03b1 induces platelet aggregation and fibrin clot retraction supported by resting alphaIIbbeta3 interaction with polymerized fibrin","volume":"89","author":"Dubois","year":"2003","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0245","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/0929866526666181208170027","article-title":"Leucine rich repeat proteins: sequences, mutations, structures and diseases","volume":"26","author":"Matsushima","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0250","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1471-4906(03)00242-4","article-title":"Leucine-rich repeats and pathogen recognition in Toll-like receptors","volume":"24","author":"Bell","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0255","article-title":"Impediment of GPIb\u03b1-mediated platelet clearance by an anti-GPIb\u03b2 antibody derivative","volume":"1003","author":"Chen","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0260","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1160\/TH09-11-0751","article-title":"Role of glycoprotein Ib\u03b1 mobility in platelet function","volume":"103","author":"van der Wal","year":"2010","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0265","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3324\/haematol.2020.278242","article-title":"The GPIb\u03b1 intracellular tail-role in transducing VWF- and collagen\/GPVI-mediated signaling","volume":"107","author":"Constantinescu-Bercu","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0270","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/blood.V98.3.652","article-title":"Epitope mapping of inhibitory antibodies against platelet glycoprotein Ib alpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha","volume":"98","author":"Cauwenberghs","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0275","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/ATVBAHA.110.212316","article-title":"Platelet\/von Willebrand factor inhibitors to the rescue of ischemic stroke","volume":"30","author":"Mannucci","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0280","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1038\/s41598-021-91165-8","article-title":"In vitro assessment and phase I randomized clinical trial of anfibatide a snake venom derived anti-thrombotic agent targeting human platelet GPIb\u03b1","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0285","doi-asserted-by":"crossref","first-page":"R282","DOI":"10.1016\/S0960-9822(03)00202-1","article-title":"Platelet physiology: in cold blood","volume":"13","author":"Andrews","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0290","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.1981.tb07258.x","article-title":"Monoclonal antibody to human platelet glycoprotein I. I. Immunological studies","volume":"49","author":"McMichael","year":"1981","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0295","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1160\/TH06-06-0297","article-title":"Rational humanization of the powerful antithrombotic anti-GPIbalpha antibody: 6B4","volume":"96","author":"Fontayne","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijsu.2019.10.015","article-title":"The current state of animal models in research: a review","volume":"72","author":"Robinson","year":"2019","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0305","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/cmi.2013.19","article-title":"Translating translational research: mouse models of human disease","volume":"10","author":"Burkhardt","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0310","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40164-022-00273-2","article-title":"The GPIb-IX complex on platelets: insight into its novel physiological functions affecting immune surveillance, hepatic thrombopoietin generation, platelet clearance and its relevance for cancer development and metastasis","volume":"11","author":"Bendas","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.140739_bb0315","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat. Med."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025012887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025012887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T04:15:03Z","timestamp":1776572103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025012887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":63,"alternative-id":["S0141813025012887"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140739","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel antibody against GPIb\u03b1 inhibits platelet function and thrombosis without increasing bleeding","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"140739"}}